Variant report
Variant | esv2762625 |
---|---|
Chromosome Location | chr6:162092293-162096566 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151196409 | chr6:162093601-162093602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533540570 | chr6:162093609-162093610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550009527 | chr6:162093611-162093612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570089625 | chr6:162093637-162093638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535519712 | chr6:162093644-162093645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368339511 | chr6:162093650-162093651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555335819 | chr6:162093664-162093665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568039351 | chr6:162093666-162093667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188750908 | chr6:162093701-162093702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551924473 | chr6:162093708-162093709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553623911 | chr6:162093733-162093734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181900483 | chr6:162093757-162093758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571678592 | chr6:162093769-162093770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114104273 | chr6:162093799-162093800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556027211 | chr6:162093802-162093803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12197876 | chr6:162093803-162093804 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs138569552 | chr6:162093807-162093808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541876383 | chr6:162093839-162093840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189244903 | chr6:162093840-162093841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181019011 | chr6:162093862-162093863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541766295 | chr6:162093879-162093880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9347532 | chr6:162093941-162093942 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs35442127 | chr6:162093952-162093953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573377126 | chr6:162093995-162093996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533368155 | chr6:162094000-162094001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550337497 | chr6:162094010-162094011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186049407 | chr6:162094022-162094023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529364273 | chr6:162094023-162094024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73786422 | chr6:162094064-162094065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368712462 | chr6:162094108-162094109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114155102 | chr6:162094113-162094114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6904356 | chr6:162094123-162094124 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs369715622 | chr6:162094150-162094151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553661515 | chr6:162094195-162094196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570717730 | chr6:162094211-162094212 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539303555 | chr6:162094229-162094230 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371805110 | chr6:162094254-162094255 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150346054 | chr6:162094256-162094257 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs207467554 | chr6:162094285-162094286 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541962238 | chr6:162094301-162094302 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113836625 | chr6:162094302-162094303 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115866488 | chr6:162094305-162094306 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574030027 | chr6:162094307-162094308 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540985976 | chr6:162094309-162094310 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544522438 | chr6:162094314-162094315 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564665630 | chr6:162094447-162094448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369728635 | chr6:162094466-162094467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533672184 | chr6:162094522-162094523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543680055 | chr6:162094560-162094561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563888128 | chr6:162094575-162094576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Parkinson disease | 0 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:162093600-162094400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr6:162094000-162094200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr6:162094200-162094400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:162094200-162094400 | Enhancers | Psoas Muscle | Psoas |
5 | chr6:162094400-162097000 | Weak transcription | Psoas Muscle | Psoas |
6 | chr6:162094400-162103200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |